Finance

Lists
Outlook: 76.2% bullish·0.0% bearish
Go to analysis
CDNA:NASDAQ
CareDx Inc
$85.88
-1.75%
(-1.53) 1D
$85.17
-0.83% (-0.71)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CDNA...
Open
$87.47
High
$89.14
Low
$83.06
Mkt. cap
4.51B
Avg. vol.
1.51M
Volume
2.35M
P/E ratio
35.87
52-wk high
$90.87
52-wk low
$14.27
EPS
$2.39
Beta
2.38
Shares outstanding
52.54M
No. of employees
763
Open
$87.47
High
$89.14
Low
$83.06
Mkt. cap
4.51B
Avg. vol.
1.51M
Volume
2.35M
P/E ratio
35.87
52-wk high
$90.87
52-wk low
$14.27
EPS
$2.39
Beta
2.38
Shares outstanding
52.54M
No. of employees
763
News stories
From web sources and news partners
About CareDx Inc
CEOJohn Hanna
Employees763
Founded1998
Headquarters-
SectorBiotechnology
Websitecaredx.com
Analyst ratings
Based on 5 analysts giving stock ratings to CDNA in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CDNA in the last 3 months.
Highest
Current $85.88
$99.00 (+15.28%)
Average
$83.50 (-2.77%)
Lowest
$64.00 (-25.48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Hold
Reiterated
$90.00
+4.8%
11/02/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$99.00
+15.3%
10/30/2026
Mark Massaro
BTIG
Buy
Maintained
$81.00
-5.7%
10/27/2026
William Bonello
Craig-Hallum
Buy
Upgraded
$64.00
-25.5%
08/03/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
08/03/2026
Evan Stampler
Wells Fargo
Hold
Maintained
$21.00
-75.5%
07/29/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
$21.00
-75.5%
07/29/2026
Andrew Brackmann
William Blair
Hold
Reiterated
-
-
05/27/2026
Unknown Analyst
Stephens
Buy
Maintained
$28.00
-67.4%
04/29/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$21.00
-75.5%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
108.39M
117.70M
131.95M
139.36M
Cost of goods sold
35.51M
33.63M
34.97M
40.29M
Cost of revenue
35.51M
33.63M
34.97M
40.29M
Research and development expenses
19.31M
21.42M
22.38M
21.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.61M
60.86M
74.35M
65.94M
Operating expense
78.91M
82.27M
96.72M
87.26M
Total operating expenses
114.43M
115.90M
131.69M
127.55M
Operating income
-6.04M
1.80M
257.00K
11.81M
Other non operating income
264.00K
-330.00K
-440.00K
372.00K
EBT including unusual items
-3.76M
2.78M
114.52M
10.69M
EBT excluding unusual items
-2.49M
3.38M
1.55M
14.39M
Income tax expense
345.00K
-32.00K
3.88M
-8.60M
Effective tax rate
-9.17%
-1.15%
3.39%
-80.43%
Other operating expenses
-
-
-
-
Net income
-4.11M
2.81M
110.64M
19.29M
Net profit margin
-3.79%
2.39%
83.85%
13.84%
Earnings per share
0.12
0.34
0.37
0.70
Interest and investment income
3.29M
1.91M
1.74M
2.21M
Interest expense
-
-
-
-
Net interest expenses
3.29M
1.91M
1.74M
2.21M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.16M
5.70M
3.07M
19.02M
Gain or loss from assets sale
48.00K
119.00K
-112.88M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps